🧪 UPDATED DAILY FROM CLINICALTRIALS.GOVSynced today

Find Clinical Trials for Your Rare Disease

12361+ recruiting trials across all rare diseases. Filter by phase, location, and condition.

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Showing 20 of 12361 recruiting trials

Phase 2RecruitingNCT06527300

A Multicenter, Open-label, Single-arm, Phase II Study of NHWD-870 HCl in Adults and Adolescents with Advanced NUT Cancer

🏥 Zhejiang Wenda Pharma Technology LTD.📍 1 site📅 Started Apr 2024View details ↗
Phase 2Enrolling by InvitationNCT06410859

Botulinum Toxin Type A for Injection (HengLi®) in the Treatment of Trigeminal Neuralgia

🏥 LKGS_277📍 1 site📅 Started Apr 2024View details ↗
Phase 2RecruitingNCT06248515

A Phase II Trial of Sacituzumab Govitecan in Patients With Advanced Thymic Epithelial Tumors

👨‍⚕️ Chul Kim, MD, Chul.Kim@gunet.georgetown.edu📍 4 sites📅 Started Apr 2024View details ↗
Phase 1RecruitingNCT06403735

A Phase I Clinical Study of QLC1101 in Patients With Advanced Solid Tumors

🏥 Qilu Pharmaceutical Co., Ltd.📍 5 sites📅 Started Apr 2024View details ↗
NARecruitingNCT06523452

Laser Speckle Imaging During Breast Reconstruction

👨‍⚕️ Lucy Gates, PhD📍 1 site📅 Started Apr 2024View details ↗
Phase 2RecruitingNCT06393985

Decitabine, Venetoclax and Blinatumomab for Maintenance Following HSCT in Patients With Ph-Negative B-ALL

👨‍⚕️ Xiaowen Tang, Ph.D, The First Affiliated Hospital of Soochow University📍 1 site📅 Started Apr 2024View details ↗
Phase 2RecruitingNCT05681195

Zanubrutinib With Pemetrexed to Treat Relapsed/Refractory Primary and Secondary Central Nervous System (CNS) Lymphomas

👨‍⚕️ Yuliya Linhares, M.D., Miami Cancer Institute at Baptist Health, Inc.📍 1 site📅 Started Apr 2024View details ↗
RecruitingNCT06430762

Therapeutic Exposures and Risk Factors in MRONJ

👨‍⚕️ Ferit Bayram, PhD, Marmara University Faculty of Dentistry📍 1 site📅 Started Apr 2024View details ↗
Phase 1RecruitingNCT06431685

Safety and Efficacy of Whole Brain LDRT+ICI+Intrathecal Chemotherapy in Refractory Meningeal Metastasis of Lung Cancer

👨‍⚕️ You Lu, MD, West China Hospital📍 1 site📅 Started Apr 2024View details ↗
Phase 1, PHASE2RecruitingNCT05665361

Palbociclib and Sasanlimab for the Treatment of Advanced Clear Cell Renal Cell Carcinoma (ccRCC) or Papillary Renal Cell Carcinoma (pRCC)

👨‍⚕️ Ramaprasad Srinivasan, M.D., National Cancer Institute (NCI)📍 1 site📅 Started Apr 2024View details ↗
RecruitingNCT06349642

Immune Checkpoint Inhibitor Response in Solid Tumors Using a Live Tumor Diagnostic Platform

👨‍⚕️ Dev Mukhopadhyay, PhD, Mayo Clinic📍 3 sites📅 Started Apr 2024View details ↗
NARecruitingNCT06479304

The Efficacy and Safety of HCQ Plus Pred in ANA Positive ITP

👨‍⚕️ Yunfeng Cheng, Shanghai Zhongshan Hospital📍 7 sites📅 Started Apr 2024View details ↗
Phase 3RecruitingNCT06284434

Liposomal Bupivacaine Use in Alveolar Bone Graft Patients

👨‍⚕️ Chad A. Purnell, MD, Shriners Hospitals for Children📍 1 site📅 Started Apr 2024View details ↗
NARecruitingNCT06479317

The Efficacy and Safety of HCQ Plus DEX in ANA Positive ITP

👨‍⚕️ Yunfeng Cheng, Shanghai Zhongshan Hospital📍 7 sites📅 Started Apr 2024View details ↗
NARecruitingNCT06379646

An Clinical Study of YTS109 Cell Injection in Subjects With Recurrent/Refractory Autoimmune Disease

👨‍⚕️ Huji Xu, MD,Ph.D, Shanghai Changzheng Hospital📍 1 site📅 Started Apr 2024View details ↗
Phase 3Enrolling by InvitationNCT06312189

Long-term Study to Evaluate Safety and Tolerability of Valbenazine in Participants With Chorea Associated With Huntington Disease in Canada

👨‍⚕️ Clinical Development Lead, Neurocrine Biosciences📍 3 sites📅 Started Apr 2024View details ↗
NARecruitingNCT06376110

Single-Blind Study Assessing the Use of a Topical Antioxidant With A Series of Laser Procedures to Reduce Sebum Production

👨‍⚕️ Edward Lain, MD, MBA, Austin Institute for Clinical Research📍 1 site📅 Started Apr 2024View details ↗
NARecruitingNCT06027255

Long COVID Immune Profiling

🏥 Vanderbilt University Medical Center📍 1 site📅 Started Apr 2024View details ↗
Phase 1, PHASE2RecruitingNCT06114511

A Study of BL-M07D1 in Patients With HER2-mutated, Locally Advanced or Metastatic Non-small-cell Lung Cancer

👨‍⚕️ Li Zhang, PHD, Sun Yat-sen University📍 1 site📅 Started Apr 2024View details ↗
Phase 1, PHASE2RecruitingNCT06503107

Nanobody-based Biepitope CAR-T Cells Targeting BCMA in the Treatment of R/RMM

🏥 Union Hospital, Tongji Medical College, Huazhong University of Science and Technology📍 1 site📅 Started Apr 2024View details ↗
← PreviousPage 303 of 619Next →

Get alerts when new trials open

Create a free account to follow conditions and receive trial notifications.

Create free account →